Robert Newton
- Biological Psychiatry top 0.5%
- Immunology top 0.5%
- Immune Response and Inflammation 52
- Behavioral Neuroscience top 1%
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 46
- Immunology and Allergy top 0.5%
-
- Asthma and respiratory diseases 49
-
- Cytokine Signaling Pathways and Interactions 48
- Peptidase Inhibition and Analysis 14
-
- Inflammatory mediators and NSAID effects 24
-
- Receptor Mechanisms and Signaling 16
- Phosphodiesterase function and regulation 15
- Co-authors
- Peter J. BarnesNeil S. HoldenMark A. GiembyczPeggy ScherleIan M. AdcockCarl P. DeciccoMaryanne CovingtonL.M. Kuitert
- Journals
- Bioorganic & Medicinal Chemistry Letters (18 papers)Molecular Pharmacology (16 papers)Journal of Biological Chemistry (16 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert Newton
264 papers receiving 13.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biological Psychiatry 493
- Immunology 3.6k
- Behavioral Neuroscience 486
- Cancer Research 2.0k
- Immunology and Allergy 773
Countries citing papers authored by Robert Newton
This map shows the geographic impact of Robert Newton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Newton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Newton more than expected).
Fields of papers citing papers by Robert Newton
This network shows the impact of papers produced by Robert Newton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Newton. The network helps show where Robert Newton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Newton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2020 | 7 | |
| 4 | Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinibbreakdown → | 2020 | 191 |
| 5 | 2020 | 12 | |
| 6 | The Hardness of the Wheat Kernel in Relation to Protein Content. | 2016 | 0 |
| 7 | 2013 | 1 | |
| 8 | 2011 | 190 | |
| 9 | 2011 | 69 | |
| 10 | 2011 | 1 | |
| 11 | 2009 | 10 | |
| 12 | 2006 | 104 | |
| 13 | 2005 | 107 | |
| 14 | 2003 | 21 | |
| 15 | 2001 | 63 | |
| 16 | International collaboration on HIV and cancer | 2000 | 66 |
| 17 | 1996 | 121 | |
| 18 | 1988 | 21 | |
| 19 | 1987 | 16 | |
| 20 | Internal breakdown in crown of red clover. | 1960 | 4 |
About Robert Newton
Robert Newton is a scholar working on Immunology, Cancer Research, Biological Psychiatry, Oncology and Immunology and Allergy, having authored 268 papers that have together received 13.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (52 papers), Asthma and respiratory diseases (49 papers), Cytokine Signaling Pathways and Interactions (48 papers), NF-κB Signaling Pathways (46 papers), Inflammatory mediators and NSAID effects (24 papers), Receptor Mechanisms and Signaling (16 papers), Phosphodiesterase function and regulation (15 papers) and Peptidase Inhibition and Analysis (14 papers). The work is most often cited by research in Biological Psychiatry (493 citations), Immunology (3.6k citations), Behavioral Neuroscience (486 citations), Cancer Research (2.0k citations) and Immunology and Allergy (773 citations). Robert Newton has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Peter J. Barnes, Neil S. Holden, Mark A. Giembycz, Peggy Scherle, Ian M. Adcock, Carl P. Decicco, Maryanne Covington, L.M. Kuitert, Martin Bergmann and Richard Leigh. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Pharmacology, Journal of Biological Chemistry, British Journal of Pharmacology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.